metastat Search Results


90
Rockland Immunochemicals humanized anti erbb2 monoclonal antibody herceptin
Humanized Anti Erbb2 Monoclonal Antibody Herceptin, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/metastat/pm18654610-23-30-66?v=Rockland+Immunochemicals
Average 90 stars, based on 1 article reviews
humanized anti erbb2 monoclonal antibody herceptin - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

94
Boster Bio hair cells
Hair Cells, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/metastat/pm41507369-285-0-12?v=Boster+Bio
Average 94 stars, based on 1 article reviews
hair cells - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

90
Rockland Immunochemicals herceptin
Herceptin, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/metastat/us12290569-2326-23-40?v=Rockland+Immunochemicals
Average 90 stars, based on 1 article reviews
herceptin - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Novus Biologicals lymph node metastatic primary tumors
Figure 1. rSlit-N treatment inhibits breast cancer growth and metastases. A, Mammary glands were isolated from MMTV-PyMT at different stages of tumor progression and tissue sections were stained with hematoxylin and eosin (H&E) or immunostained with Slit2 antibody using the IHC technique. B, Eight-weeks-old MMTV-PyMT mice bearing spontaneous mammary tumors were treated with rSlit2-N or PBS for 4 weeks. C, Tumor volume was measured every week up to 12 weeks of age. D, Representative pictures of the lungs harvested from B. E, The number of <t>metastatic</t> nodules in the lungs. F–M, MVT1 cells were orthotopically implanted into the 6-week-old FVB wild-type mice. F, Schematics of mice treatment with rSlit2-N or PBS. N ¼ 6 mice in each group. G, Tumor volume was measured every week. H, Representative pictures of the lungs harvested from F. I, The number of metastatic nodules in the lungs. J, Schematics of mice treatment with rSlit2-N or PBS, showing Slit2-treated tumors were allowed to grow for additional 2 weeks. N ¼ 5 mice in each group. K, At the end, tumors were harvested and weight was measured. L, Representative pictures of the lungs harvested from J. M, The number of metastatic nodules in the lungs. N, Human breast cancer cell line MDA-MB-231 overexpressing Slit2 (231-Slit2) or vector control (231-Vec) implanted orthotopically into the NSG mice. O, After 2 weeks of tumor injection, tumor volume was measured every week up to the age of 12 weeks. P, The images of lungs harvested from N. Q, The harvested lungs were analyzed for the number of metastatic nodules using a dissection microscope. R–U, NSG females were injected with MDA-MB-231 cells and treated with Adeno-Slit2 or Adeno-Null. R, Schematics of mice treatment with Adeno-Slit2 or Adeno-Null. S, Starting from 8 weeks of age, tumor volume was measured every week. T, Representative pictures of the lungs harvested from R. U, The number of metastatic nodules in the lungs. , P < 0.05; , P < 0.01; , P < 0.001; NS, P value not significant using Student t test.
Lymph Node Metastatic Primary Tumors, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/metastat/10__1158_slash_0008___5472__can___20___3909-150-17-23?v=Novus+Biologicals
Average 90 stars, based on 1 article reviews
lymph node metastatic primary tumors - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

93
ATCC metastatic melanoma skin cell line
Figure 1. rSlit-N treatment inhibits breast cancer growth and metastases. A, Mammary glands were isolated from MMTV-PyMT at different stages of tumor progression and tissue sections were stained with hematoxylin and eosin (H&E) or immunostained with Slit2 antibody using the IHC technique. B, Eight-weeks-old MMTV-PyMT mice bearing spontaneous mammary tumors were treated with rSlit2-N or PBS for 4 weeks. C, Tumor volume was measured every week up to 12 weeks of age. D, Representative pictures of the lungs harvested from B. E, The number of <t>metastatic</t> nodules in the lungs. F–M, MVT1 cells were orthotopically implanted into the 6-week-old FVB wild-type mice. F, Schematics of mice treatment with rSlit2-N or PBS. N ¼ 6 mice in each group. G, Tumor volume was measured every week. H, Representative pictures of the lungs harvested from F. I, The number of metastatic nodules in the lungs. J, Schematics of mice treatment with rSlit2-N or PBS, showing Slit2-treated tumors were allowed to grow for additional 2 weeks. N ¼ 5 mice in each group. K, At the end, tumors were harvested and weight was measured. L, Representative pictures of the lungs harvested from J. M, The number of metastatic nodules in the lungs. N, Human breast cancer cell line MDA-MB-231 overexpressing Slit2 (231-Slit2) or vector control (231-Vec) implanted orthotopically into the NSG mice. O, After 2 weeks of tumor injection, tumor volume was measured every week up to the age of 12 weeks. P, The images of lungs harvested from N. Q, The harvested lungs were analyzed for the number of metastatic nodules using a dissection microscope. R–U, NSG females were injected with MDA-MB-231 cells and treated with Adeno-Slit2 or Adeno-Null. R, Schematics of mice treatment with Adeno-Slit2 or Adeno-Null. S, Starting from 8 weeks of age, tumor volume was measured every week. T, Representative pictures of the lungs harvested from R. U, The number of metastatic nodules in the lungs. , P < 0.05; , P < 0.01; , P < 0.001; NS, P value not significant using Student t test.
Metastatic Melanoma Skin Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/metastat/pm37524884-46-17-23?v=ATCC
Average 93 stars, based on 1 article reviews
metastatic melanoma skin cell line - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

93
Boster Bio foxp3
Effect of flavonoids and scutebarbatines in SB on the levels of immune factors in Lewis tumor-bearing mice. All data were expressed as means ± SD ( n = 9).
Foxp3, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/metastat/pmc04433671-48-8-26?v=Boster+Bio
Average 93 stars, based on 1 article reviews
foxp3 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

92
StressMarq anti her2
( A ) <t>HER2</t> (diamonds), TNBC (circles), and luminal (squares and triangles) breast cancer lines were seeded into 96-well plates and treated with increasing doses of MAL3-101 for 72 hr. Viability is expressed as the average of three or more independent experiments, ± SEM. ( B ) MAL3-101-sensitive (MCF7 and MDA MB 231, denoted in blue) and resistant (MDA MB 453 and MDA MB 361, denoted in black) cells were treated with 12 µM MAL3-101 for the indicated times, and lysates were prepared and immunoblotted for cleaved caspase-3, caspase-7, and caspase-8. β-actin serves as a loading control. ( C ) The corresponding fold-increase of the indicated apoptotic markers relative to the DMSO control are plotted, ± SEM (n≥3 for cleaved caspase-3, n=3 for cleaved caspase-7, and n≥4 for cleaved caspase-8). Black asterisks correspond to statistical significance between MDA MB 231 cells (closed circle) and MDA MB 453 and MDA MB 361 (open circle and triangle, respectively), and the red asterisk represents statistical significance between MCF7 (closed triangle) and MDA MB 453 and MDA MB 361 (open circle and triangle) cells; * denotes p<0.05, ** denotes p<0.005. Figure 1—source data 1. Source data for cell viability assay and apoptotic marker accumulation in .
Anti Her2, supplied by StressMarq, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/metastat/pmc08275131-386-69-58?v=StressMarq
Average 92 stars, based on 1 article reviews
anti her2 - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

93
Boster Bio rabbit
( A ) <t>HER2</t> (diamonds), TNBC (circles), and luminal (squares and triangles) breast cancer lines were seeded into 96-well plates and treated with increasing doses of MAL3-101 for 72 hr. Viability is expressed as the average of three or more independent experiments, ± SEM. ( B ) MAL3-101-sensitive (MCF7 and MDA MB 231, denoted in blue) and resistant (MDA MB 453 and MDA MB 361, denoted in black) cells were treated with 12 µM MAL3-101 for the indicated times, and lysates were prepared and immunoblotted for cleaved caspase-3, caspase-7, and caspase-8. β-actin serves as a loading control. ( C ) The corresponding fold-increase of the indicated apoptotic markers relative to the DMSO control are plotted, ± SEM (n≥3 for cleaved caspase-3, n=3 for cleaved caspase-7, and n≥4 for cleaved caspase-8). Black asterisks correspond to statistical significance between MDA MB 231 cells (closed circle) and MDA MB 453 and MDA MB 361 (open circle and triangle, respectively), and the red asterisk represents statistical significance between MCF7 (closed triangle) and MDA MB 453 and MDA MB 361 (open circle and triangle) cells; * denotes p<0.05, ** denotes p<0.005. Figure 1—source data 1. Source data for cell viability assay and apoptotic marker accumulation in .
Rabbit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/metastat/pm40446580-100-8-13?v=Boster+Bio
Average 93 stars, based on 1 article reviews
rabbit - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
Proteintech bambi
Figure 4. TLR4 <t>orchestrates</t> <t>TGF-β/Smads</t> signaling to promote pathogen-associated biliary fibrosis caused by Clonorchis sinensis. Livers from TLR4 wild and mutated mice infected with or without C. sinensis were harvested, and the sections of tissue containing bile ducts were homogenated for western-blot. (A–D): the relative expression of TGF-β1 (B), p-Smad2/3 (C) and <t>BAMBI</t> (D) were analyzed in the liver of TLR4wild/ TLR4mut mice infected with or without C. sinensis-infected by Western blotting. The blots of each group were run under the same experimental conditions and the images were from the same gel. The data were obtained from 3~5 mice of three-independent experiment. The values were expressed as mean ± SEM. Compared with indicated group, *P < 0.05, **P < 0.01, ***P < 0.001.
Bambi, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/metastat/pm28634394-110-43-45?v=Proteintech
Average 90 stars, based on 1 article reviews
bambi - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

92
Boster Bio pbs txnip
Figure 2: Effects of systemic hypoxia stimulation on the expression of <t>TXNIP/NLRP3</t> signaling pathway-related factors in periodontal tissues of rats: (a) immunofluorescence staining (IF) showed that TXNIP, NLRP3, ASC, and caspase-1 in periodontal tissues. Ab: alveolar; PL: periodontal ligament; R: root. Scale bars = 25 μm. (b) RT-PCR analysis of TXNIP, NLRP3, ASC, caspase-1, and IL-1β in periodontal tissues (n = 5). (c) Western blotting analysis of TXNIP, NLRP3, ASC, caspase-1, and IL-1β in periodontal tissues (n = 5 for each group). The above data are presented as the mean ± SEM, ∗p < 0:05.
Pbs Txnip, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/metastat/pm35083332-130-16-20?v=Boster+Bio
Average 92 stars, based on 1 article reviews
pbs txnip - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

90
Boster Bio mouse anti human her
Figure 2: Effects of systemic hypoxia stimulation on the expression of <t>TXNIP/NLRP3</t> signaling pathway-related factors in periodontal tissues of rats: (a) immunofluorescence staining (IF) showed that TXNIP, NLRP3, ASC, and caspase-1 in periodontal tissues. Ab: alveolar; PL: periodontal ligament; R: root. Scale bars = 25 μm. (b) RT-PCR analysis of TXNIP, NLRP3, ASC, caspase-1, and IL-1β in periodontal tissues (n = 5). (c) Western blotting analysis of TXNIP, NLRP3, ASC, caspase-1, and IL-1β in periodontal tissues (n = 5 for each group). The above data are presented as the mean ± SEM, ∗p < 0:05.
Mouse Anti Human Her, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/metastat/pmc05539487-109-26-34?v=Boster+Bio
Average 90 stars, based on 1 article reviews
mouse anti human her - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Figure 1. rSlit-N treatment inhibits breast cancer growth and metastases. A, Mammary glands were isolated from MMTV-PyMT at different stages of tumor progression and tissue sections were stained with hematoxylin and eosin (H&E) or immunostained with Slit2 antibody using the IHC technique. B, Eight-weeks-old MMTV-PyMT mice bearing spontaneous mammary tumors were treated with rSlit2-N or PBS for 4 weeks. C, Tumor volume was measured every week up to 12 weeks of age. D, Representative pictures of the lungs harvested from B. E, The number of metastatic nodules in the lungs. F–M, MVT1 cells were orthotopically implanted into the 6-week-old FVB wild-type mice. F, Schematics of mice treatment with rSlit2-N or PBS. N ¼ 6 mice in each group. G, Tumor volume was measured every week. H, Representative pictures of the lungs harvested from F. I, The number of metastatic nodules in the lungs. J, Schematics of mice treatment with rSlit2-N or PBS, showing Slit2-treated tumors were allowed to grow for additional 2 weeks. N ¼ 5 mice in each group. K, At the end, tumors were harvested and weight was measured. L, Representative pictures of the lungs harvested from J. M, The number of metastatic nodules in the lungs. N, Human breast cancer cell line MDA-MB-231 overexpressing Slit2 (231-Slit2) or vector control (231-Vec) implanted orthotopically into the NSG mice. O, After 2 weeks of tumor injection, tumor volume was measured every week up to the age of 12 weeks. P, The images of lungs harvested from N. Q, The harvested lungs were analyzed for the number of metastatic nodules using a dissection microscope. R–U, NSG females were injected with MDA-MB-231 cells and treated with Adeno-Slit2 or Adeno-Null. R, Schematics of mice treatment with Adeno-Slit2 or Adeno-Null. S, Starting from 8 weeks of age, tumor volume was measured every week. T, Representative pictures of the lungs harvested from R. U, The number of metastatic nodules in the lungs. , P < 0.05; , P < 0.01; , P < 0.001; NS, P value not significant using Student t test.

Journal: Cancer Research

Article Title: Slit2 Inhibits Breast Cancer Metastasis by Activating M1-Like Phagocytic and Antifibrotic Macrophages

doi: 10.1158/0008-5472.can-20-3909

Figure Lengend Snippet: Figure 1. rSlit-N treatment inhibits breast cancer growth and metastases. A, Mammary glands were isolated from MMTV-PyMT at different stages of tumor progression and tissue sections were stained with hematoxylin and eosin (H&E) or immunostained with Slit2 antibody using the IHC technique. B, Eight-weeks-old MMTV-PyMT mice bearing spontaneous mammary tumors were treated with rSlit2-N or PBS for 4 weeks. C, Tumor volume was measured every week up to 12 weeks of age. D, Representative pictures of the lungs harvested from B. E, The number of metastatic nodules in the lungs. F–M, MVT1 cells were orthotopically implanted into the 6-week-old FVB wild-type mice. F, Schematics of mice treatment with rSlit2-N or PBS. N ¼ 6 mice in each group. G, Tumor volume was measured every week. H, Representative pictures of the lungs harvested from F. I, The number of metastatic nodules in the lungs. J, Schematics of mice treatment with rSlit2-N or PBS, showing Slit2-treated tumors were allowed to grow for additional 2 weeks. N ¼ 5 mice in each group. K, At the end, tumors were harvested and weight was measured. L, Representative pictures of the lungs harvested from J. M, The number of metastatic nodules in the lungs. N, Human breast cancer cell line MDA-MB-231 overexpressing Slit2 (231-Slit2) or vector control (231-Vec) implanted orthotopically into the NSG mice. O, After 2 weeks of tumor injection, tumor volume was measured every week up to the age of 12 weeks. P, The images of lungs harvested from N. Q, The harvested lungs were analyzed for the number of metastatic nodules using a dissection microscope. R–U, NSG females were injected with MDA-MB-231 cells and treated with Adeno-Slit2 or Adeno-Null. R, Schematics of mice treatment with Adeno-Slit2 or Adeno-Null. S, Starting from 8 weeks of age, tumor volume was measured every week. T, Representative pictures of the lungs harvested from R. U, The number of metastatic nodules in the lungs. , P < 0.05; , P < 0.01; , P < 0.001; NS, P value not significant using Student t test.

Article Snippet: To analyze Slit2 expression in human samples, we purchased two tissue microarrays (TMA) having normal, invasive, and lymph node metastatic primary tumors from Imgenex (IMH-364 and BR1008).

Techniques: Isolation, Staining, Plasmid Preparation, Control, Injection, Dissection, Microscopy

Figure 6. Slit2 expression levels predict breast cancer patient survival. A, Human breast tissue microarray (pilot TMA) was immunostained with Slit2 antibody using IHC. Representative images showing Slit2 expression levels in normal (n ¼ 10), infiltrative ductal carcinoma (IDC; n ¼ 50), and lymph node-positive metastatic (LNþ metastatic) (n ¼ 40) breast tissues. B, The graph depicts the percentage of human breast samples expressing different levels of Slit2. C, The expression level of Slit2 in human breast tissues using UALCAN database. BL1, basal-like 1; BL2, basal-like 2; IM, immunomodulatory; LAR, luminal androgen receptor; M, mesenchymal; MSL, mesenchymal stem-like; UNS, unspecified. D, Analysis of Slit2 gene copy number in The Cancer Genome Atlas dataset using Oncomine. DC, ductal carcinoma (n-5); IDC & ILC, invasive ductal and invasive lobular carcinoma (n-5); IDC & LC, invasive ductal and lobular carcinoma (n-14); IDC, invasive ductal carcinoma (n-639); N, normal breast (n-111). E, Using experimental TMA, the association of Slit2 protein expression levels with patient survival was analyzed. The Kaplan–Meier graph demonstrating the association of Slit2 expression level with patient survival. F, Analysis of breast cancer patient overall survival based on expression levels of Slit2 mRNA in the Kaplan–Meier plotter database (n ¼ 1115). G, Analysis of breast cancer lymph node-positive (LNþ) metastases patient survival based on expression levels of Slit2 in the Kaplan–Meier plotter database (n ¼ 936).

Journal: Cancer Research

Article Title: Slit2 Inhibits Breast Cancer Metastasis by Activating M1-Like Phagocytic and Antifibrotic Macrophages

doi: 10.1158/0008-5472.can-20-3909

Figure Lengend Snippet: Figure 6. Slit2 expression levels predict breast cancer patient survival. A, Human breast tissue microarray (pilot TMA) was immunostained with Slit2 antibody using IHC. Representative images showing Slit2 expression levels in normal (n ¼ 10), infiltrative ductal carcinoma (IDC; n ¼ 50), and lymph node-positive metastatic (LNþ metastatic) (n ¼ 40) breast tissues. B, The graph depicts the percentage of human breast samples expressing different levels of Slit2. C, The expression level of Slit2 in human breast tissues using UALCAN database. BL1, basal-like 1; BL2, basal-like 2; IM, immunomodulatory; LAR, luminal androgen receptor; M, mesenchymal; MSL, mesenchymal stem-like; UNS, unspecified. D, Analysis of Slit2 gene copy number in The Cancer Genome Atlas dataset using Oncomine. DC, ductal carcinoma (n-5); IDC & ILC, invasive ductal and invasive lobular carcinoma (n-5); IDC & LC, invasive ductal and lobular carcinoma (n-14); IDC, invasive ductal carcinoma (n-639); N, normal breast (n-111). E, Using experimental TMA, the association of Slit2 protein expression levels with patient survival was analyzed. The Kaplan–Meier graph demonstrating the association of Slit2 expression level with patient survival. F, Analysis of breast cancer patient overall survival based on expression levels of Slit2 mRNA in the Kaplan–Meier plotter database (n ¼ 1115). G, Analysis of breast cancer lymph node-positive (LNþ) metastases patient survival based on expression levels of Slit2 in the Kaplan–Meier plotter database (n ¼ 936).

Article Snippet: To analyze Slit2 expression in human samples, we purchased two tissue microarrays (TMA) having normal, invasive, and lymph node metastatic primary tumors from Imgenex (IMH-364 and BR1008).

Techniques: Expressing, Microarray

Effect of flavonoids and scutebarbatines in SB on the levels of immune factors in Lewis tumor-bearing mice. All data were expressed as means ± SD ( n = 9).

Journal: Evidence-based Complementary and Alternative Medicine : eCAM

Article Title: Inhibition of Tumor Growth and Immunomodulatory Effects of Flavonoids and Scutebarbatines of Scutellaria barbata D. Don in Lewis-Bearing C57BL/6 Mice

doi: 10.1155/2015/630760

Figure Lengend Snippet: Effect of flavonoids and scutebarbatines in SB on the levels of immune factors in Lewis tumor-bearing mice. All data were expressed as means ± SD ( n = 9).

Article Snippet: Antibodies to these immunoregulatory factors including IL-10, IL-17, FOXP3, IFN- γ , IL-2, ROR γ t, TGF- β 1, IL-6, and β -actin were obtained from Wuhan BOSTER Biological Engineering Co., Ltd. (Wuhan, China).

Techniques:

( A ) HER2 (diamonds), TNBC (circles), and luminal (squares and triangles) breast cancer lines were seeded into 96-well plates and treated with increasing doses of MAL3-101 for 72 hr. Viability is expressed as the average of three or more independent experiments, ± SEM. ( B ) MAL3-101-sensitive (MCF7 and MDA MB 231, denoted in blue) and resistant (MDA MB 453 and MDA MB 361, denoted in black) cells were treated with 12 µM MAL3-101 for the indicated times, and lysates were prepared and immunoblotted for cleaved caspase-3, caspase-7, and caspase-8. β-actin serves as a loading control. ( C ) The corresponding fold-increase of the indicated apoptotic markers relative to the DMSO control are plotted, ± SEM (n≥3 for cleaved caspase-3, n=3 for cleaved caspase-7, and n≥4 for cleaved caspase-8). Black asterisks correspond to statistical significance between MDA MB 231 cells (closed circle) and MDA MB 453 and MDA MB 361 (open circle and triangle, respectively), and the red asterisk represents statistical significance between MCF7 (closed triangle) and MDA MB 453 and MDA MB 361 (open circle and triangle) cells; * denotes p<0.05, ** denotes p<0.005. Figure 1—source data 1. Source data for cell viability assay and apoptotic marker accumulation in .

Journal: eLife

Article Title: Unique integrated stress response sensors regulate cancer cell susceptibility when Hsp70 activity is compromised

doi: 10.7554/eLife.64977

Figure Lengend Snippet: ( A ) HER2 (diamonds), TNBC (circles), and luminal (squares and triangles) breast cancer lines were seeded into 96-well plates and treated with increasing doses of MAL3-101 for 72 hr. Viability is expressed as the average of three or more independent experiments, ± SEM. ( B ) MAL3-101-sensitive (MCF7 and MDA MB 231, denoted in blue) and resistant (MDA MB 453 and MDA MB 361, denoted in black) cells were treated with 12 µM MAL3-101 for the indicated times, and lysates were prepared and immunoblotted for cleaved caspase-3, caspase-7, and caspase-8. β-actin serves as a loading control. ( C ) The corresponding fold-increase of the indicated apoptotic markers relative to the DMSO control are plotted, ± SEM (n≥3 for cleaved caspase-3, n=3 for cleaved caspase-7, and n≥4 for cleaved caspase-8). Black asterisks correspond to statistical significance between MDA MB 231 cells (closed circle) and MDA MB 453 and MDA MB 361 (open circle and triangle, respectively), and the red asterisk represents statistical significance between MCF7 (closed triangle) and MDA MB 453 and MDA MB 361 (open circle and triangle) cells; * denotes p<0.05, ** denotes p<0.005. Figure 1—source data 1. Source data for cell viability assay and apoptotic marker accumulation in .

Article Snippet: For the remaining proteins aliquots from the same lysates were instead heated to 37°C for 30 min prior to SDS-PAGE using 4–20% Tris-Glycine gradient gels (XP04202Box, Thermo Fisher Scientific), and after transfer on nitrocellulose membranes (#84–874, Prometheus Laboratories Inc, California), the blots were incubated with anti-cleaved Caspase-8 (18C8, #9496; at 1:1000), anti-BiP (C50B12, #3177S; at 1:1000), anti-Hsp70 (smc-113, StressMarq Biosciences, Victoria, British Columbia; at 1:1000), anti-Hsc/Hsp70 (#4872S; at 1:1000), anti-HER2 (29D8, #2165; at 1:2000), anti-eIF2α (#9722S; at 1:2000), anti-phospho-eIF2α (#9721L; at 1:500), anti-PERK (D11A8, #5683S; at 1:2000), anti-PKR (D7F7, #12297S; at 1:2000), anti-Ire1α (14C10, #3294S; at 1:1000), anti-HRI (MBS2538114, MyBioSource, San Diego, CA; at 1:500) and anti-GCN2 and anti-GCN2 pT899 antibody (ab-134053 and ab-75836, Abcam, Cambtidge, UK; at 1:2000).

Techniques: Viability Assay, Marker

Breast cancer cells exhibit a range of sensitivities to MAL3-101, a specific Hsp70 inhibitor. The indicated breast cancer lines were seeded into 96-well plates and treated with increasing doses of the indicated compounds for 72 hr. Viability was measured using the CellTiter-Glo assay. IC 50 values were generate using a sigmoidal nonlinear regression with SigmaPlot 11.0. ND stands for an undetermined value. MAL3-101 sensitivities of Hsp70 inhibitor resistant cells are in bold.

Journal: eLife

Article Title: Unique integrated stress response sensors regulate cancer cell susceptibility when Hsp70 activity is compromised

doi: 10.7554/eLife.64977

Figure Lengend Snippet: Breast cancer cells exhibit a range of sensitivities to MAL3-101, a specific Hsp70 inhibitor. The indicated breast cancer lines were seeded into 96-well plates and treated with increasing doses of the indicated compounds for 72 hr. Viability was measured using the CellTiter-Glo assay. IC 50 values were generate using a sigmoidal nonlinear regression with SigmaPlot 11.0. ND stands for an undetermined value. MAL3-101 sensitivities of Hsp70 inhibitor resistant cells are in bold.

Article Snippet: For the remaining proteins aliquots from the same lysates were instead heated to 37°C for 30 min prior to SDS-PAGE using 4–20% Tris-Glycine gradient gels (XP04202Box, Thermo Fisher Scientific), and after transfer on nitrocellulose membranes (#84–874, Prometheus Laboratories Inc, California), the blots were incubated with anti-cleaved Caspase-8 (18C8, #9496; at 1:1000), anti-BiP (C50B12, #3177S; at 1:1000), anti-Hsp70 (smc-113, StressMarq Biosciences, Victoria, British Columbia; at 1:1000), anti-Hsc/Hsp70 (#4872S; at 1:1000), anti-HER2 (29D8, #2165; at 1:2000), anti-eIF2α (#9722S; at 1:2000), anti-phospho-eIF2α (#9721L; at 1:500), anti-PERK (D11A8, #5683S; at 1:2000), anti-PKR (D7F7, #12297S; at 1:2000), anti-Ire1α (14C10, #3294S; at 1:1000), anti-HRI (MBS2538114, MyBioSource, San Diego, CA; at 1:500) and anti-GCN2 and anti-GCN2 pT899 antibody (ab-134053 and ab-75836, Abcam, Cambtidge, UK; at 1:2000).

Techniques:

The cell numbers and autophagy or proteasome inhibitor concentrations used for the cell viability assay in combination with increasing doses of MAL3-101 are shown. The concentrations of bortezomib, CQ, and bafilomycin to induce no greater than 30% of cell death in each line after 72 hr treatment are shown. ND stands for undetermined value.

Journal: eLife

Article Title: Unique integrated stress response sensors regulate cancer cell susceptibility when Hsp70 activity is compromised

doi: 10.7554/eLife.64977

Figure Lengend Snippet: The cell numbers and autophagy or proteasome inhibitor concentrations used for the cell viability assay in combination with increasing doses of MAL3-101 are shown. The concentrations of bortezomib, CQ, and bafilomycin to induce no greater than 30% of cell death in each line after 72 hr treatment are shown. ND stands for undetermined value.

Article Snippet: For the remaining proteins aliquots from the same lysates were instead heated to 37°C for 30 min prior to SDS-PAGE using 4–20% Tris-Glycine gradient gels (XP04202Box, Thermo Fisher Scientific), and after transfer on nitrocellulose membranes (#84–874, Prometheus Laboratories Inc, California), the blots were incubated with anti-cleaved Caspase-8 (18C8, #9496; at 1:1000), anti-BiP (C50B12, #3177S; at 1:1000), anti-Hsp70 (smc-113, StressMarq Biosciences, Victoria, British Columbia; at 1:1000), anti-Hsc/Hsp70 (#4872S; at 1:1000), anti-HER2 (29D8, #2165; at 1:2000), anti-eIF2α (#9722S; at 1:2000), anti-phospho-eIF2α (#9721L; at 1:500), anti-PERK (D11A8, #5683S; at 1:2000), anti-PKR (D7F7, #12297S; at 1:2000), anti-Ire1α (14C10, #3294S; at 1:1000), anti-HRI (MBS2538114, MyBioSource, San Diego, CA; at 1:500) and anti-GCN2 and anti-GCN2 pT899 antibody (ab-134053 and ab-75836, Abcam, Cambtidge, UK; at 1:2000).

Techniques: Viability Assay

Breast cancer cells exhibit a range of sensitivities to MAL3-101 in the presence of either autophagy or proteasome inhibitors. Cells were seeded into 96-well plates and treated with increasing doses of MAL3-101 in the presence or absence of subcritical doses of bortezomib (proteasome inhibitor), or CQ or bafilomycin (autophagy inhibitors) for 72 hr. Viability was measured using the CellTiter-Glo assay. IC 50 values were generate using a sigmoidal nonlinear regression with SigmaPlot 11.0. ND stands for undetermined value. MAL3-101 resistant cells are highlighted in yellow.

Journal: eLife

Article Title: Unique integrated stress response sensors regulate cancer cell susceptibility when Hsp70 activity is compromised

doi: 10.7554/eLife.64977

Figure Lengend Snippet: Breast cancer cells exhibit a range of sensitivities to MAL3-101 in the presence of either autophagy or proteasome inhibitors. Cells were seeded into 96-well plates and treated with increasing doses of MAL3-101 in the presence or absence of subcritical doses of bortezomib (proteasome inhibitor), or CQ or bafilomycin (autophagy inhibitors) for 72 hr. Viability was measured using the CellTiter-Glo assay. IC 50 values were generate using a sigmoidal nonlinear regression with SigmaPlot 11.0. ND stands for undetermined value. MAL3-101 resistant cells are highlighted in yellow.

Article Snippet: For the remaining proteins aliquots from the same lysates were instead heated to 37°C for 30 min prior to SDS-PAGE using 4–20% Tris-Glycine gradient gels (XP04202Box, Thermo Fisher Scientific), and after transfer on nitrocellulose membranes (#84–874, Prometheus Laboratories Inc, California), the blots were incubated with anti-cleaved Caspase-8 (18C8, #9496; at 1:1000), anti-BiP (C50B12, #3177S; at 1:1000), anti-Hsp70 (smc-113, StressMarq Biosciences, Victoria, British Columbia; at 1:1000), anti-Hsc/Hsp70 (#4872S; at 1:1000), anti-HER2 (29D8, #2165; at 1:2000), anti-eIF2α (#9722S; at 1:2000), anti-phospho-eIF2α (#9721L; at 1:500), anti-PERK (D11A8, #5683S; at 1:2000), anti-PKR (D7F7, #12297S; at 1:2000), anti-Ire1α (14C10, #3294S; at 1:1000), anti-HRI (MBS2538114, MyBioSource, San Diego, CA; at 1:500) and anti-GCN2 and anti-GCN2 pT899 antibody (ab-134053 and ab-75836, Abcam, Cambtidge, UK; at 1:2000).

Techniques:

Figure 4. TLR4 orchestrates TGF-β/Smads signaling to promote pathogen-associated biliary fibrosis caused by Clonorchis sinensis. Livers from TLR4 wild and mutated mice infected with or without C. sinensis were harvested, and the sections of tissue containing bile ducts were homogenated for western-blot. (A–D): the relative expression of TGF-β1 (B), p-Smad2/3 (C) and BAMBI (D) were analyzed in the liver of TLR4wild/ TLR4mut mice infected with or without C. sinensis-infected by Western blotting. The blots of each group were run under the same experimental conditions and the images were from the same gel. The data were obtained from 3~5 mice of three-independent experiment. The values were expressed as mean ± SEM. Compared with indicated group, *P < 0.05, **P < 0.01, ***P < 0.001.

Journal: Scientific reports

Article Title: The roles of Toll-like receptor 4 in the pathogenesis of pathogen-associated biliary fibrosis caused by Clonorchis sinensis.

doi: 10.1038/s41598-017-04018-8

Figure Lengend Snippet: Figure 4. TLR4 orchestrates TGF-β/Smads signaling to promote pathogen-associated biliary fibrosis caused by Clonorchis sinensis. Livers from TLR4 wild and mutated mice infected with or without C. sinensis were harvested, and the sections of tissue containing bile ducts were homogenated for western-blot. (A–D): the relative expression of TGF-β1 (B), p-Smad2/3 (C) and BAMBI (D) were analyzed in the liver of TLR4wild/ TLR4mut mice infected with or without C. sinensis-infected by Western blotting. The blots of each group were run under the same experimental conditions and the images were from the same gel. The data were obtained from 3~5 mice of three-independent experiment. The values were expressed as mean ± SEM. Compared with indicated group, *P < 0.05, **P < 0.01, ***P < 0.001.

Article Snippet: Membranes were then incubated with primary rabbit antibodies: α-SMA (1:1000, UCallM biotech Co., Ltd, Wuxi, China), MyD88 (1:1000, UCallM biotech Co., Ltd, Wuxi, China), p-NF-κB (1:1000, UCallM biotech Co., Ltd, Wuxi, China), TGF-β1 (1:1000, Affinity Biosciences, OH, USA), p-Smad2/3 (1:1000, Proteintech, Wuhan, China), BAMBI (1:1000, Proteintech, Figure 4.

Techniques: Infection, Western Blot, Expressing

Figure 2: Effects of systemic hypoxia stimulation on the expression of TXNIP/NLRP3 signaling pathway-related factors in periodontal tissues of rats: (a) immunofluorescence staining (IF) showed that TXNIP, NLRP3, ASC, and caspase-1 in periodontal tissues. Ab: alveolar; PL: periodontal ligament; R: root. Scale bars = 25 μm. (b) RT-PCR analysis of TXNIP, NLRP3, ASC, caspase-1, and IL-1β in periodontal tissues (n = 5). (c) Western blotting analysis of TXNIP, NLRP3, ASC, caspase-1, and IL-1β in periodontal tissues (n = 5 for each group). The above data are presented as the mean ± SEM, ∗p < 0:05.

Journal: BioMed research international

Article Title: Effects of Hypoxic Environment on Periodontal Tissue through the ROS/TXNIP/NLRP3 Inflammasome Pathway.

doi: 10.1155/2022/7690960

Figure Lengend Snippet: Figure 2: Effects of systemic hypoxia stimulation on the expression of TXNIP/NLRP3 signaling pathway-related factors in periodontal tissues of rats: (a) immunofluorescence staining (IF) showed that TXNIP, NLRP3, ASC, and caspase-1 in periodontal tissues. Ab: alveolar; PL: periodontal ligament; R: root. Scale bars = 25 μm. (b) RT-PCR analysis of TXNIP, NLRP3, ASC, caspase-1, and IL-1β in periodontal tissues (n = 5). (c) Western blotting analysis of TXNIP, NLRP3, ASC, caspase-1, and IL-1β in periodontal tissues (n = 5 for each group). The above data are presented as the mean ± SEM, ∗p < 0:05.

Article Snippet: For IF, the sections were incubated overnight at 4°Cwith primary antibodies (1 : 250) diluted in PBS: TXNIP (Rabbit IgG, Boster, China), NLRP3 (Rabbit IgG, Boster, China), ASC (Rabbit IgG, Immunoway, USA), and caspase-1 (Rabbit IgG, Immunoway, China) and then incubated with Alexa Fluor-488 and Alexa Fluor-555 conjugate secondary antibodies at room temperature for 1h.

Techniques: Expressing, Staining, Reverse Transcription Polymerase Chain Reaction, Western Blot